| CD4 T-cell exhaustion: does it exist and what are its roles in cancer? AM Miggelbrink, JD Jackson, SJ Lorrey, ES Srinivasan, J Waibl-Polania, ... Clinical Cancer Research 27 (21), 5742-5752, 2021 | 153 | 2021 |
| Editing the sickle cell disease mutation in human hematopoietic stem cells: comparison of endonucleases and homologous donor templates Z Romero, A Lomova, S Said, A Miggelbrink, CY Kuo, ... Molecular therapy 27 (8), 1389-1406, 2019 | 105 | 2019 |
| CD8+ T cells maintain killing of MHC-I-negative tumor cells through the NKG2D–NKG2DL axis EC Lerner, KI Woroniecka, VM D’Anniballe, DS Wilkinson, AA Mohan, ... Nature Cancer 4 (9), 1258-1272, 2023 | 44 | 2023 |
| B-cell differentiation and IL-21 response in IL2RG/JAK3 SCID patients after hematopoietic stem cell transplantation AM Miggelbrink, BR Logan, RH Buckley, RE Parrott, CC Dvorak, ... Blood, The Journal of the American Society of Hematology 131 (26), 2967-2977, 2018 | 42 | 2018 |
| Neuronal CaMKK2 promotes immunosuppression and checkpoint blockade resistance in glioblastoma WH Tomaszewski, J Waibl-Polania, M Chakraborty, J Perera, J Ratiu, ... Nature Communications 13 (1), 6483, 2022 | 18 | 2022 |
| Outcomes of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome R Labrosse, JI Chu, MA Armant, JK Everett, D Pellin, N Kareddy, ... Blood 142 (15), 1281-1296, 2023 | 13 | 2023 |
| Pushing Past the Blockade: Advancements in T Cell-Based Cancer Immunotherapies J Waibl Polania, EC Lerner, DS Wilkinson, A Hoyt-Miggelbrink, PE Fecci Frontiers in Immunology 12, 777073, 2021 | 9 | 2021 |
| Broad immunophenotyping of the murine brain tumor microenvironment WH Tomaszewski, J Waibl-Polania, AM Miggelbrink, MA Chakraborty, ... Journal of immunological methods 499, 113158, 2021 | 4 | 2021 |
| Systemic immune derangements are shared across various CNS pathologies and reflect novel mechanisms of immune privilege SJ Lorrey, J Waibl Polania, LP Wachsmuth, A Hoyt-Miggelbrink, ZP Tritz, ... Neuro-Oncology Advances 5 (1), vdad035, 2023 | 3 | 2023 |
| Intracranial tumors elicit systemic sympathetic hyperactivity that limits immunotherapeutic responses SJ Lorrey, L Wachsmuth, J Finlay, J Waibl Polania, A Hoyt-Miggelbrink, ... bioRxiv, 2023.11. 02.565368, 2023 | | 2023 |
| Antigen presentation by tumor-associated macrophages mediates progenitor to terminal exhaustion transition in GBM and other solid tumors J Waibl Polania, AM Hoyt-Miggelbrink, WH Tomaszewski, LP Wachsmuth, ... bioRxiv, 2023.08. 11.553007, 2023 | | 2023 |
| Comparing Two Gene Therapy Approaches for the Treatment of Sickle Cell Disease: Gene Correction vs. Allelic Disruption J Sanchez, M Velez, A Miggelbrink, Z Romero, D Kohn Experimental Hematology 64, S100, 2018 | | 2018 |
| Using HUDEP Cells as a Model for Gene Editing for-Thalassemia and Sickle Cell Disease M Velez, J Sanchez, A Miggelbrink, Z Romero, D Kohn Experimental Hematology 64, S108, 2018 | | 2018 |
| Comparison of Endonucleases and DNA Donor Template Delivery Methods to Improve Site Specific Gene Correction in Hematopoietic Stem Cells Z Romero, A Miggelbrink, A Lomova, CY Kuo, B Campo-Fernandez, ... MOLECULAR THERAPY 26 (5), 84-84, 2018 | | 2018 |
